Strategies for a particular drug delivery are always of great interest for the pharmaceutical industry, and efficient methods of preparing products with controlled particle microstructures are fundamental for the development and application of drug delivery. Supercritical fluid particle design (SCF PD) processes, as a green and effective alternative to traditional methods, have been effectively employed to produce particles with designated microstructures.
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Abstract
Strategies for a particular drug delivery are always of great interest for the pharmaceutical industry, and efficient methods of preparing products with controlled particle microstructures are fundamental for the development and application of drug delivery. Supercritical fluid particle design (SCF PD) processes, as a green and effective alternative to traditional methods, have been effectively employed to produce particles with designated microstructures.
Combining with research experiences in our research group, this review aims to provide a theoretical framework of SCF PD for particular drug delivery. For any drug delivery formulations, macroscopic properties are directly influenced by the particle microstructures, "Inverse" strategies are introduced at first to obtain the needed particle microstructures for a particular drug delivery in this paper. Then, how to produce particles with designated microstructures via SCF PD processes is discussed, mainly focus on the screening and selection of operating parameters according to thermodynamics and fluid dynamics study. Recent examples of SCF micronization and co-precipitation/ encapsulation processes are also summarized with an emphasis on how to tailor the particle microstructures by controlling the operating parameters.
Finally, challenges and issues needed further study are briefly suggested for SCD PD.
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INTRODUCTION
Strategies for effective drug delivery are always of great interest for the pharmaceutical industry [1] , especially the delivery of particular drugs with poor solubility, tissue damage on extravasation, rapid breakdown of the drug in vivo, unfavorable pharmacokinetics, poor biodistribution and lack of selectivity for target tissues [2] [3] [4] .
Drug delivery process includes the administration of the therapeutic product, the release of the active ingredients by the product, and the subsequent transport of the active ingredients across the biological membranes to the site of action [5, 6] . For a particular drug delivery, macroscopic properties, such as the administration methods, drug release and targeting are determined according to the drug properties and its application. These macroscopic properties are directly influenced by the particle microstructures, such as morphology, particle size (PS), particle size distribution (PSD), crystal form, drug loading (DL) and encapsulation efficiency (EE) [7, 8] . Thus, the efficient methods of preparing products with controlled particle microstructures are fundamental for the development and application of any drug delivery formulations.
York [9] indicated that an ideal particle formation process for the pharmaceutical industry should be clean, environmentally responsible, single-step operation producing particles with targeted properties. Supercritical fluid (SCF) processes, as an alternative strategy of traditional technologies, provide an attractive platform to achieve these aims and show great promise in particle design [10, 11] . As the most popular SCF, supercritical CO2 (scCO2) is safe, inexpensive, readily available, and an ideal substitute for many hazardous and toxic solvents. By controlling the level of pressure (P), temperature (T), or modifier, scCO2 dissolves a broad range of compounds, both polar and non-polar. At present, scCO2 process is one of the fastest growing technologies being adopted by the pharmaceutical industry [12] .
As noted by Elvassore and Kikic [13] , the concepts of "clean or green chemistry" and "sustainable technology" are of great help to make pharmaceutical industrial applications of SCF processes closer than ever. SCF processes and their fundamentals have been discussed in many reviews, these reviews mainly focus in the use of SCF processes for different pharmaceuticals applications, and occasionally for modeling or fundamentals of these processes [14] [15] [16] . Combining with research experiences in our laboratory, this review aims to provide a theoretical framework of SCF particle design (SCF PD) for particular drug delivery.
An overall view of SCF PD for particular drug delivery is shown in Fig.1 . "Inverse" strategies are introduced at first to establish the relationship between particular drug delivery and particle microstructures. Then, tailoring particle microstructures via a suitable SCF processes is discussed with an emphasis on the screening and selection of operating parameters according to thermodynamics and fluid dynamics study. Typical examples of SCF micronization and co-precipitation/encapsulation processes for particular drug delivery are summarized.
BASIC REQUIREMENTS OF PARTICULAR DRUG DELIVERY
For all particular drug delivery, the administration methods of the therapeutic product should be determined at first, drugs are introduced into the human body by various routes [5, 17] , where the selection of these administration methods depends on the disease, the effect desired and the product available [18] . The most common administration methods with their advantages and disadvantages are listed in Table 1 .
Every administration method has certain requirements on particle microstructures, especially on PS [19] [20] [21] [22] [23] . Generally, for oral administration, there is a wide PS range, which tends to be within 0.1-100m, according to their gastrointestinal dissolution and absorption characteristics. For injection, the particles in the intravenous solution are distributed to various organs depending on PS. Particles larger than 7 m are trapped in the lungs, and those smaller than 0.1 m accumulate in the bone marrow.
Those with diameter between 0.1 and 7 m are taken up by the liver and the spleen.
For transdermal administration, particles greater than 10 m remain on the skin surface; particles between 3-10 m concentrate in the hair follicles; particles smaller than 3 m may penetrate both the follicles and stratum corneum. PS also exerts a significant influence on pulmonary drug delivery. Particles with mass median aerodynamic diameter ranging from 1-5 m, are deposited in the bronchial and alveolar regions predominantly by sedimentation, and have the best pulmonary penetration.
For most particular drug delivery, the drug release behaviors should also be considered. Although vesicles or drug macromolecule conjugates may prolong release, optimal control is afforded if the drug is placed in a polymeric material [24] .
Polymeric materials generally release drugs by the following mechanisms [25] : (i) diffusion, (ii) chemical reaction, or (iii) solvent activation. There are two types of diffusion-controlled systems: reservoirs (Fig. 2 A) and matrices (Fig. 2 B) . Chemical control is accomplished either by polymer degradation (Fig. 2 C) or chemical cleavage of the drug from a polymer (Fig. 2 D) . Solvent activation involves either swelling of the polymer (Fig. 2 E) or osmotic effects (Fig. 2 F and G) .
These drug release mechanisms depend on a number of parameters [26] . Some of them are external, such as concentration of the active substance and carrier in the surrounding medium, pH, and enzymatic action. However, most of them are particle microstructures, such as PS, morphology, crystal form, DL, etc. The quantitative interpretation of the values, which obtained in the dissolution assay, is facilitated by the usage of a generic equation, where the equation mathematically translates the dissolution curve in function of some parameters related with the particle microstructures. There are number of kinetic models, which described the overall release of drug from the dosage forms [27] . These methods are classified into three categories: (a) statistical methods, e.g. exploratory data analysis method, repeated measures design, multivariate approach and multivariate analysis of variance [28, 29] ; (b) model dependent methods, e.g. zero order, first order, Higuchi, Korsmeyer-Peppas model, Hixson Crowell, Baker-Lonsdale model and Weibull model [30, 31] ; and (c) model independent methods [32, 33] .
Conventional forms of drugs normally medicate the whole body, reaching healthy areas as well as diseased. Thus, for some particular drug delivery, the transport of the active ingredients to the site of action should be taken into account.
Targeted drug delivery refers to predominant drug accumulation within a target zone, which is independent of the method and route of drug administration [34] . The following advantages of drug targeting are evident [35] [36] [37] : (a) drug administration protocols may be simplified; (b) drug quantity required to achieve a therapeutic effect may be greatly reduced as well as the cost of therapy; (c) drug concentration in the required sites can be sharply increased without negative effects on non-target compartments. There are a number of parameters that are important for the successful development and manufacturing of targeted drug delivery. The targeting of drugs may be viewed on two levels: (a) organ targeting and (b) cellular targeting. The organ targeting is actually dependent on the size, shape and material properties of the carrier employed, whereas the cellular targeting depends upon a more specific interaction at a molecular level between the carrier and the cellular target. Thus, the targeted delivery systems have significant requirements on particle microstructures. For example, surface properties of nontargeted drug delivery vehicles affect the particle uptake, where the size of the nanoparticles affects their movement in and out of the vasculature, whereas the margination of particles to vessel wall is impacted by their shape, as shown in Fig. 3 [38] .
SUPERCRITICAL FLUID PARTICLE DESIGN
Generally, SCF PD processes are classified into three major methods [39] , i.e., rapid expansion of supercritical solution (RESS), particles from gas-saturated solution (PGSS) process, supercritical antisolvent (SAS) process. Table 2 lists their various modifications, which depends on whether the scCO2 used as a solvent, a solute or an antisolvent. As well known, knowledge about these processes is of great help to the selection of a suitable SCF process for a particular drug delivery.
SCF PD Processes and Their Modifications
RESS was patented in 1986 [40] , and exploits the ability of the scCO2 to solubilize different compounds. The advantages of RESS include that it is a simple process, and is relatively easy to implement on a small scale. However, the main drawback that limits the scaling of this process is represented by great SCF/solution rate requirement, since the poor solubility of most pharmaceutical products in scCO2.
Usually, the solubility value for obtaining a reasonable yield should be on the order of 10 -4 mole fraction. Therefore, several modifications have been implemented for the RESS process, including RESS into a liquid solvent (RESOLV) [41] , RESS into an aqueous solution (RESSAS) [42] , RESS-non-solvent (RESS-N) process [43] , RESS with solid cosolvent (RESS-SC) [44] [45] [46] , pre-filtration RESS (PF-RESS) [47] , etc.
Recently, these RESS processes were specified by Türk [48] .
PGSS process uses the property of CO2 can be solubilised in large quantities in a liquid or a melted solid [49] . The advantages of the PGSS process are similar to those of RESS. These processes perform the production of solvent-free material, as there is no need of organic solvents. Further advantages of the PGSS process are low consumption of CO2 and a wide range of potential applications, since the solubility of compressed gases in liquids and solids is often high. Particularly, PGSS process is potentially adaptable to protein and lipid processing, and is properly applied to materials with low melting points. Nevertheless, the different physicochemical properties of proteins and lipids may result in large and inhomogeneous particles.
Thus, Salmaso et al [50] developed a novel supercritical gas-assisted melting atomization process (GAMA process) to produce the solid lipid submicron particles.
GAMA process improved the atomization of PGSS process by using a second gas in the atomization and precipitation vessel. The PGSS process can also be used to produce particles from aqueous solutions. PGSS-drying is the most used PGSS variation, which was developed by Meterc et al [51] for drying of aqueous green tea extracts. Compared with spray-drying, PGSS-drying provides an inert atmosphere avoiding the possibility of the oxidation. Moreover, PGSS-drying allows drying the solutions with a reduced thermal degradation or contamination of the product, because PGSS-drying is carried out in a closed system, and only the static mixer section of the process operates at high T.
SAS is devised to precipitate solid compounds that are not soluble in SCF. Many variations of the SAS technique exist, including the gas antisolvent (GAS) recrystallization, aerosol solvent extraction systems (ASES) and precipitation with compressed antisolvent (PCA) process. GAS is a batch process and the earliest SAS technology, which was proposed in 1989 by Gallagher et al [52] . ASES and PCA are semi-continuous processes, which are devised based on the concept of the GAS. GAS process is simple and particularly useful for the crystallization of sensitive materials, e.g. pharmaceuticals, biological products, explosives, etc, since it operates at moderate T [53] . However, a clear disadvantage of GAS process is the lack of effective control on the particle formation. Problems also exist in GAS process, such as exothermic impact during the addition of SCF into solvent or solution. Main advantage of PCA and ASES over GAS is their suitability for continuous operation, which is prerequisite for large scale mass production of particles. To some degree, SAS processes usually means ASES or PCA in many researches. In PCA and ASES, to minimize particle agglomeration frequently observed and to reduce or eliminate drying times, increased mass-transfer rates are required. This has been successfully achieved in the solution enhanced dispersion by SCF (SEDS) process [54] , which uses a coaxial nozzle design with a mixing chamber. In addition, to obtain ultrafine particles with narrow size distribution, He et al [55, 56] used SEDS with prefilming atomization (SEDS-PA) process. The principle involved in SEDS-PA is to drive the liquid atomized along a surface as a film within the nozzle, and consequently reaching at the atomizing edge. Besides, the SAS with enhanced mass transfer (SAS-EM) technique, conceived by Chattopadhyay and Gupta [57] , utilizes a deflecting surface that vibrates at ultrasonic frequencies to enhance the atomization of the solution.
Screening and Selection of Operating Parameters
As mentioned above, RESS can be used with scCO2-soluble molecules, PGSS can be used with CO2-dissolved molecules, while SAS can process nonsoluble molecules. For a particular drug delivery, a suitable method is selected based on the drug properties. However, there are many operating parameters for SCF PD processes that have great influence on particle microstructures, as shown in Table 2 . Study about the complicated mechanism of particle formation and growth is essential to screening and selection of the operating parameters for producing particles with designated microstructures.
For modeling of SCF processes, a general dynamic equation for simultaneous nucleation, condensation and coagulation is implemented, as described in Eq. (1) [58, 59] .
where n denotes the PSD function, t is the time, J is the nucleation rate, v is the particle volume, v* is the critical volume, is the standard Dirac function, G is the condensation growth rate,is the Brownian coagulation coefficient. Furthermore, it is worthy to notice that the driving force of nucleation and crystal growth for all SCF processes is the solution supersaturation (S), which is a measurement of the difference of solute concentration between the composition of the fluid (y), and the saturation composition (yeq), defined as Eq.(2) [60] . 
Based on the S value, the particle nucleation and growth kinetics can be established.
By means of the classical nucleation theory, the nucleation rate J, the critical nucleus size r* and the number concentration of critical nuclei N* for homogeneous nucleation are given by Eqs. (3) (4) (5) , respectively [60] .
where, is the non-isothermal factor, is the Zeldovich nonequilibrium factor, c is the condensation coefficient, ns is the number of condensable molecules, c is the mean thermal velocity, is the solid-fluid interfacial tension, kB is the Boltzmann's constant and v S is the solid molecular volume. After nucleation, the particle assumes to grow up until S disappears. The growth of the particles could be governed by the diffusion where the diffusion coefficient of the solute in the dense fluid can be calculated from the Stokes-Einstein equation. The growth rate of particle diameter with t thus may be estimated as given below [61] . 
where Dp is the diameter of the particles, Kn is the Knudsen number, and DC is the diffusion coefficient of the solute in a SCF as follows. where M is the solvent molecular weight and is the pure solvent viscosity.
Thus, S is a key factor to determine the product quality, especially the particle microstructures. In general, high S cause fast nucleation and crystal growth, therefore a larger number of smaller particles are produced when S is increased. As shown in Therefore, to establish the relationship between operating parameters and particle microstructures, it is of great importance to get a rational understanding of the thermodynamics and fluid dynamics.
Thermodynamics study
In a SCF process, thermodynamics is mainly focuses on the study of the solubility of the substance in CO2 at high P, maybe with some amount of organic solvents. This is vital for setting operating parameters, e.g., T, P and organic solvents.
Solute solubility data in the SCF can be collected from the literature when they exist, or be obtained from experiments or modeling. Solubility data for 783 different compounds published from the early 1960s to 2004 are presented by Gupta et al [62] .
Solubility data for solid compounds in sub-and supercritical fluids reported in the literature between 2005 and 2010 are summarized by S kerget et al [63] . However, most of these data are for binary systems, solubility data for ternary and multicomponent systems are still limited. Various methods to measure solubility in SCF can be divided into two major categories, i.e. static and dynamic [62] [63] [64] . For example, the supercritical phase behaviors of the poly(lactic acid)/poly(ethylene glycol)/poly(lactic acid) (PLLA-PEG-PLLA) + CO2 + dichloromethane (DCM) system and the PLLA-PEG-PLLA + CO2 + DCM + Ethanol (EtOH) system were investigated using the static method [65] . The effects of T, the mass fraction of DCM (or DCM + EtOH) (w), the PEG mass fraction (f) in PLLA-PEG-PLLA on cloud-point P were shown in Fig. 5 .
The solubility of a pure solid component in a SCF can be expressed as a function of the operating P and T. However, the calculation of phase equilibrium at high P presents several peculiarities: (a) many methods originally developed for low P calculations, are not applicable at high P; (b) the behavior of the fluid can be strongly affected by the presence of a component at near-critical conditions; and (c) the mixtures of interest frequently include components with large differences in molecular weight or polarity. Models for supercritical-phase equilibriums fall into several categories. The most common method treats the SCF phase as a dense gas, and uses an equation of state (EOS) to calculate the fugacity coefficient of the solute in the fluid phase, e.g., the Peng-Robinson (PR) equation (Eq. (8)) [66, 67] .
This type of equations establishes a relation between P, T and molar volume (v). In order to take into account the non-ideal behaviour, energetic parameters (a) and covolume (b) must be introduced. There are also a large number of semiempirical correlations, such as the Chrastil's equation (Eq. (9)) [68, 69] .
Eq. (9) is based on the solvate complex formed between solute and SCF at equilibrium, proposing a relation between y and the density of the SCF ( 1). It can be seen that three parameters (e, A and B) must be determined for Eq. (9) by regressing experimental against theoretical data.
Based on thermodynamic study, phase diagrams can be depicted to decide the process paths of various SCF processes. The most applicable phase diagram for the binary solid-scCO2 systems in RESS and PGSS is shown in Fig. 6 [70, 71] . The solid-liquid-vapor (S-L-V) lines intersect with the critical lines (L=V) at two distinguished point, i.e. the lower critical end point (LCEP) and the upper critical end point (UCEP). For RESS, depending on the pre-expansion and expansion of P and T, the expansion trajectory may cross the V-L line of CO2, thus leading to the formation of liquid CO2 droplets. In some cases, the expansion path may even intersect the S-L line of the diagram, so CO2 snow is produced, which causes severe safety problems of clogging, especially if CO2 freezes inside the expansion nozzle. In RESS, therefore, it is important to predict the behavior of the solubility in the SCF near the UCEP, in order to choose P and T values which give the maximum amount of solute in scCO2 without appearance of a liquid phase. Investigation on the PGSS thermodynamics has been performed by Elvassore et al [72] though calculating the enthalpy changes along the process with the perturbed-hard-sphere-chain-theory EOS. Results indicated that the melting point was found to decrease when increasing P, until a minimum in the melting point was reached; afterwards, the melting point was increasing together with P. In PGSS, the P−T trace of the S−L−V equilibrium gives information on P needed to melt the solute and form a liquid phase at a given T, and to calculate its composition.
A simple representative phase diagram of the ternary solid-solvent-SCF systems at constant T and P is shown in Fig. 7 , where dashed arrows represent the process paths of various SCF processes. At P above the critical point of the binary organic solvent-SCF mixture, the number of coexisting phases reduces from six to four [73] .
About ternary mixtures, which are mostly related to SAS, a phase behavior study of the system is extremely useful to address the feasibility of the process and to exploit the effects of T and P [74] . Moreover, alternative polymeric particle topography and shapes depended upon process paths followed in the phase diagram were reported.
For example, Reverchon et al [75] performed an experimental study on SAS precipitation to gain insight into the role of phase behavior and atomization in controlling morphology and dimension of precipitates. Results showed that operating above the mixture critical point (MCP) of the ternary mixture yttrium acetate/dimethyl sulfoxide (DMSO)/CO2, sub-micrometric particles were generated nearly independently from the size of the injector and of the apparatus. The results also show that it is possible to modify the particle dimension by simply changing the operating P and/or T in the vicinity of the MCP. The use of a pseudo-binary diagram P-molar fraction has been proposed as a base framework to explain the relationship between the particle morphology and the phase behavior of processed mixtures.
Particularly, it is found that the single-phase region in the gas-rich side of the P−composition diagram and below the MCP is usefully explored to modify the particle dimensions of the precipitate.
Fluid dynamics
One of the main aspects of fluid dynamics is the study of jet hydrodynamic, which contributes to the nozzle design and selection of other operating parameters.
Nozzle design includes geometry, size, distance and angle of impact against the surface of the jet stream [76] .
A schematic of the RESS expansion device is displayed in Fig. 8 . From the nozzle exit, the fluid expands as a supersonic free jet followed by another subsonic jet where the jet interacts significantly with the background gas present in the expansion region. These two jet regions are separated by the Mach disk [77] . Referring to Fig. 8 , the relation between the jet height 2r along the expansion pathway to the Mach disk, with the distance x is expressed as Eq. 10.
where Lnozzle and LM are the length of the nozzle and the length of the supersonic free jet region, respectively, DM denotes the diameter of the Mach disk. The LM and DM can be calculated from the following Eqs. (11) and (12) based on the nozzle diameter Dnozzle, pre-expansion pressure P0 and expansion pressure Ppost, respectively [78] .
Weber et al [79] studied the influence of the capillary geometry by calculating the PSD resulting from nozzles with different Lnozzle/Dnozzle ratios. As Lnozzle/Dnozzle increases, the major part of the P drop is due to friction and is shifted closer to the exit (in normalized distances). Thus, expansions in long capillaries are closer to isenthalpic paths, in contrast to the virtually isentropic paths followed by expansions in short devices. Size distribution of particles generated in long capillaries is generally broader. In expansion devices with high Lnozzle/Dnozzle ratios, bimodal PSD may occur because of the second burst of nucleation. Reverchon et al [80] also demonstrates that for small Lnozzle/Dnozzle orifices a large part of the P drop, and almost all T decrease associated with RESS take place in the post-expansion chamber. This observation confirms the important role of the process parameters connected to the post-expansion device. The nozzle needs to be maintained at a suitable pre-expansion T to prevent the premature precipitation of the solute. Some researches use the nozzle T as an additional parameter for the control of particle characteristics, although the influence of this parameter is usually limited [81] .
PGSS process has similar jet hydrodynamic with RESS process. The nozzle hydrodynamics of the PGSS process is contained in the papers of Li et al [82, 83] for the CO2 and hydrogenated palm oil (HPO) system. An annular mist flow at the exit of the nozzle with an existing equilibrium between the CO2-rich gas phase and the mixed CO2-HPO liquid phase was considered. The results indicated that at the exit of the nozzle, PSD is narrower with a smaller PS because the particles are formed by melt crystallization, but if the particle formation is due to an atomization process, PSD is larger and wider. In many cases the number percentage of particles produced by the melt crystallization process prevail over that produced by the atomization process.
Usually, only high pre-expansion T can produce particles mainly from atomization.
The Dnozzle has only a negligible effect on the produced PS, but has a more evident effect on PSD. Large Dnozzle usually produce unimodal distribution particles.
To study the hydrodynamics of the SAS process, most authors assumed that the jet of organic solvent behaves like a liquid jet injected into a gas. This supposition allows applying the classic theory of jet break-up. The break-up length of the jet is studied and correlated as a function of the Reynolds (Re) and Weber numbers (We ), defined as Eqs (13) and (14) . (14) where, u is the velocity.
However, three different phenomena can be observed when the solution is injected into scCO2, i.e., (a) jet break-up into rather large droplets (drops), (b) jet atomization into small droplets, and (c) "gas-plume" like mixing, when no droplets are formed, as shown in Fig. 9 [84] . The classic theory of jet break-up is disabled when the jet spreads forming a gas-plume.
To overcome this shortage, Martín et al [85] considered jet hydrodynamics as the mixing of two completely miscible fluids forming a gas-plume, and is modeled with a k-turbulence model, which consists of two semi-empirical equations for the turbulent kinetic energy k, and the turbulent kinetic energy dissipation rate .
Lengsfeld et al [86] developed a method for predicting dynamic surface tension and combined this method with linear jet breakup equations to accurately predict jet breakup lengths in immiscible to highly miscible systems. For highly miscible systems, they proposed that microparticle formation results from gas-phase nucleation and growth within the expanding plume, rather than by nucleation within discrete liquid droplets.
Furthermore, Reverchon et al [87] proposed a possible formation mechanism of nanoparticles and microparticles, which is based on the competition between two characteristic times: (a) time of jet break-up ( jb), i.e., the time required to the liquid jet to break at the exit of the nozzle; (b)time of surface tension vanishing ( stv), i.e., the time required to reduce to near zero the surface tension of the liquid in the SCF mixture formed in the precipitator. The results indicated that if stv < jb, nanoparticles formation by "gas to particle" precipitation is observed. Instead, if stv < jb, microparticles formation by micrometric droplets drying is the prevailing process.
Further explanations of the occurrence of typically produced particle morphologies have been suggested in other works of Reverchon et al [84, [88] [89] [90] , where the elastic or inelastic in situ light scattering techniques were used to gain direct information about the mechanisms involved in the SAS process.
The formation mechanisms of amorphous nano-, micro-, or expanded micro particles are well analyzed and well understood based on time scale approaches.
While, Rossmann et al [91] indicated that this time scale model is not applicable for systems forming crystalline structures. The saturation solubility of the solute in mixtures of solvents and antisolvents was proposed as the indirect classification criterion to distinguish amorphous precipitating or crystallizing. Furthermore, Dowy et al [92] developed an optical method to measure the supersaturation in situ for SAS process. Firstly, saturation mole fractions of the solute were measured via elastic light scattering. Secondly, the actual solute mole fraction was imaged in situ during the injection of the solution into the antisolvent using a Raman based optical measurement technique.
Another aspect of fluid dynamics is the study of mass transfer, especially in SAS processes. Once the droplets have been formed inside the SCF, rapid transfer of CO2 into these droplets and the solvent out of these droplets causes the droplets to expand rapidly. Werling et al [93] indicated that it is useful to define a droplet radius based on the difference in density between the solvent-rich and the antisolvent-rich regions, because the droplet radius is a key parameter for describing the extent of mass transfer and for determining the effect of process conditions on diffusion. The present mass transfer model is related to droplet turbulence studies, and a simplified continuity equation for a chemical species is expressed as Eq. (15) Besides, it is worth to note that in the SAS-EM technique, major factors responsible for size reduction are the droplet size reduction due to ultrasonic atomization and the increased mixing due to ultrasonic streaming [94] . The droplet diameter (D) is proportional to the wavelength on the liquid film surface and can be determined as [95] .
where F is the vibration frequency.
SCF PD PROCESSES FOR PARTICULAR DRUG DELIVERY
Recently, numerous studies of SCF PD processes have been reported to enhance the solubility of poorly water-soluble drugs, design the sustained release systems, and develop the targeted systems. The typical SCF PD processes for a particular drug delivery are micronization and co-precipitation/encapsulation, as shown in Fig.10 .
Micronization processes tailor PS, PSD and morphology of particles to meet the different drug administration methods, improve the bioavailability of pharmaceuticals presented in a solid formulation. Furthermore, micronization processes modify the physical structure of the crystal to obtain the polymorphic or amorphous forms, which might exhibit higher solubility and bioavailability.
Co-precipitation/encapsulation processes produce drug delivery systems (DDS) with anticipated particle microstructures, which effectively improve pharmacological and therapeutic properties of a particular drug by controlling the rate, time and place of release of drugs in the body. where the dry powders were prepared with or without an absorption enhancer (citric acid) by SAS process. Bakhbakhi et al [98] micronized beclomethasone-17, 21-dipropionate using GAS process, the results showed that the GAS process has the potential to produce steroid with powder properties suitable for inhalation therapy.
SCF Micronization Processes
Second, SCF micronization processes effectively decrease PS or produce amorphous particles, which enhance the dissolution rate and solubility of poorly water-soluble drugs. For example, Keshavarz et al [99] micronized raloxifene by RESS process, the results showed that raloxifene PS reduced from 45.28 m to 18.93 nm, and a 7-fold increase in dissolution rate was obtained. Varshosaz et al [100] produced amorphous cefuroxime axetil (CFA) nanoparticles with Z-average PS between 158 and 513 nm by RESS process, the results indicated that more than 90% of the nano-sized CFA formulations were dissolved in 3 min and complete dissolution occurred within 20 min, while the commercial CFA did not achieve complete dissolution during 60 min of the testing period. Kim et al [101] prepared amorphous atorvastatin calcium nanoparticles with mean PS ranging between 152 and 863 nm using SAS process, the results proved that the dissolution rates were highly increased by the reduction of PS resulting in an increased specific surface area, and the absorption after oral administration to rats was markedly increased.
Third, SCF micronization processes also modify the crystal form of the polymorphic drugs, which might exhibit higher solubility and bioavailability. Bolten et al [102] modified the crystal structure of carbamazepine particles by varying the pre-expansion conditions of RESS, the results demonstrated that C-monoclinic carbamazepine particles were produced at pre-expansion T higher than 363 K, while triclinic carbamazepine particles were produced at 333 K and 300 bar. Rossmann [103] crystallized paracetamol particles using SAS process, where the polymorph of paracetamol crystals was adjusted between monoclinic and orthorhombic by varying the content of ethanol in the solution. Using ethanol as the organic solvent, always the monoclinic polymorphic form I of paracetamol was generated irrespectively of the P and the concentration. It was also found that already 30% of acetone in the initial mixture is sufficient to change the polymorphic form from monoclinic to orthorhombic. Recrystallzation and micronization of 10-hydroxycamptothecin (HCPT) was investigated using SAS process in our previous study [104] , as shown in Fig.11 , two different polymorphs were found, the results also indicated that SAS process modified the form of HCPT from monohydrate to anhydrous.
Tailoring particle microstructures via SCF micronization processes
The main objective of SCF micronization processes is to produce micro-and/or nanoparticles with controlled PS, PSD, morphology and crystal form. Some recent reports of SCF micronization processes are exampled in Table 3 , which focus on how to tailor the PS by manipulating the operating parameters.
Thermodynamics are considered at first in many studies to guide the formation of drug fine particles. Huang et al [105] determined the solubility of progesterone and correlated the solubility data with three empirical density-based models and the PR EOS model before preparing progesterone fine particles with RESS. Solubility of solute in the scCO2, which is mainly controlled by extraction T and P, is an important factor for the particle formation in the RESS process, because it is directly related to S.
The results showed that increased with increasing extraction P. Besides, high extraction T induces low progesterone concentration as constant extraction P is lower than the crossover P of 210 bar, but induces high progesterone concentration as extraction P is higher than 210 bar. And small progesterone particles were obtained at high extraction P or T. Based on the progesterone solubility data, effect of extraction T and P on the average PS of produced materials are predicted and explained combined with the crystal nucleation rate and growth by coagulation or by condensation after nuclei.
Chen et al [109] employed a modified PGSS process to prepare PEG6000-ibuprofen composite particles after investigating the S-L-V phase equilibrium behavior of the PEG6000-ibuprofen-CO2 system. Then the composite powder was then dispersed into water to remove PEG6000 and obtain ibuprofen nanoparticles. The results showed that increase of the P decreases the melting T of the ibuprofen-PEG6000 mixture. According to the thermodynamics data, suitable operating T and P at different PEG molecular weight were selected, and spherical ibuprofen nanoparticles with diameter of 20-500 nm were prepared at different conditions. Theophylline microparticles were prepared by Franceschi et al [114] using SAS process, where a mixture of EtOH and DCM was used as solvents. In order to help selecting the appropriate operating conditions and understand the precipitation mechanism, the fluid phase behavior of ternary (CO2-solvents) and quaternary (CO2-solvents-theophylline) systems were investigated using a static synthetic method.
Phase diagram of the mixture revealed that the contact mechanism between solution and antisolvent occurred in two different ways, which influenced the aggregation, PS and PSD. The results verified that the addition of theophylline to the ternary system consisting of the organic solvents and CO2 did not influence the transition P, which allows the consideration of a ternary system to select the operating points in the phase diagram. PR-EOS demonstrated to be suitable for representing multicomponent systems. The precipitation T, flow rate of solution (Fs) and scCO2 (Fc), and Cd in the solution were the most important variables that affected the precipitation results.
Ultra-fine particles of -chymotrypsin were produced with SAS technique by
Chang et al [115] , it was found that the phase behavior of the mixtures during precipitation governed the product's morphology, as shown in Fig. 12 . Uniform networked nano-particles were obtained as the precipitation was implemented in the supercritical region. The uniformity of the resulting products became worse when the particles were precipitated around the critical region. Irregular micro-scale aggregated particles were formed in the superheated region, while both dense cake and spherical clusters were produced in the V-L coexistence region.
Fluid dynamics is essential to discuss the influence of flow rate and nozzle design on particle microstructures. Micronization of gemfibrozil particles was carried out using RESS process by Baseri et al [116] , where effects of spray distance, nozzle type and nozzle diameter on the characteristics of gemfibrozil particles were studied.
The results showed that two competition phenomena for spray distance, i.e., increasing effect (increase of growth time by increasing of spray distance) and decreasing effect (decrease of flow velocity by increase of spray distance) lead to make a maximum value of mean PS in the spray distance of 5.5 cm. Particles produced by capillary nozzle have higher growth time and it results in larger particles in comparison with the orifice nozzle. A larger diameter of nozzle provides only higher total flow rates without bringing about a change of axial velocity, thus it has insignificant effect on the crystallization process.
He et al [55] precipitate ephedrine from ethanol solution using SEDS-PA process, where a prefilming atomizer was designed on the basis of the mechanisms of atomization and applied to the SEDS process. It was found that PS decreases with increasing Fc, because high Fc reinforced the impingement of dense gas on the liquid film, which results in the formation of fine droplets and intense mixing of scCO2 and droplets. With the increase of Fs, PS increased in the beginning, then decreased. When Fs is low and Fc is relatively high, the impingement of the atomizing dense gas on liquid sheet is the main factor of jet breakup in the spray process and the liquid sheet is rapidly disintegrated into droplets as prompt atomization; drop sizes and PS increase with Fs for constant Fc in this case. When Fs is high and Fc is relatively low, the interaction between the liquid and the dense gas is weak and the liquid sheet is disintegrated into drops according to the wavy-sheet mechanism; in this case, PS decrease with Fs for constant Fc.
Micronization of camptothecin (CPT) has been performed using SAS process in our previous study [117] . The results indicated that solvents with higher / ratio, lower and lower solvation power will form smaller CPT microparticles with lower crystallinity. The possible reason is that higher / means the higher Re of solution at the nozzle exit, and low of the pure liquid shortens the elapsed time of the interface between injected solution and bulk CO2. These are beneficial to the formation of small droplets or "gas-plume", which provide a larger mass transfer surface between the liquid and the gaseous phase, resulting in a faster S of the solute occurring and less time for the particle growth, then forming small particles. On the other hand, at same CPT concentration, the saturation ratio is higher when using solvents with lower solvation power, and this helps to produce smaller particles.
SCF Co-precipitation/Encapsulation Processes
The formulation of drugs together with a biocompatible or biodegradable carrier material by co-precipitation/encapsulation processes has a great relevance for pharmaceutical industry. Usually, co-precipitation/encapsulation techniques are 
Objectives of SCF co-precipitation/encapsulation processes
First, sustained release systems can be designed by SCF co-precipitation/ encapsulation processes. For example, Duarte et al [118] prepared Ethylcellulose/ methylcellulose blends by solvent-evaporation and SAS process. Then, SCF impregnation was performed to prepare naproxen loaded microspheres. The results indicated that microspheres prepared by SAS process have a higher loading capacity and present a slower release profile. The systems studied present a release mechanism controlled by drug diffusion, which complies Fick's law of diffusion.
Lee et al [119] employed a modified SAS-EM process to fabricate controlled-release matrices for Paclitaxel. When ultrasonication was applied, more uniform particles in the submicron size range were obtained. In vitro release studies showed that, at DL of 3% or less, almost the entire drug is released during a 1 month period. At higher DL (10%), approximately half the drug is released during a 1 month period and subsequent release is very slow. A similar result is obtained at 5% DL. This is very likely due to the formation of drug crystals dispersed within the polymer matrix. Similar phenomenon was observed at our previous work [120] , where the micronized HCPT is dispersed into the PLLA matrix using SAS process. The result of in vitro drug release test indicated that the crystallinity of HCPT in microparticles affects the control release performance, and the good encapsulated microparticles with higher DL and higher crystallinity are better.
10-Hydroxycamptothecin proliposomes (HCPT-PL) were also prepared using the SAS process in our previous study [121] , the results showed that spherical or clavate HCPT-PL were obtained under different DL, as shown in Fig. 13 . For the optimized HCPT-PL, the residual DCM meets the ICH requirement, and part of the encapsulated HCPT still maintains its crystalline state. The result of in vitro release rate study showed that HCPT-PL sustained the HCPT release rate successfully, where the drug release of the optimized HCPT-PL followed the first order kinetics, and the drug diffusion mainly corresponded to a Fickian diffusion mechanism during the first 10 h. SCF co-precipitation/encapsulation processes are also employed to produce targeted DDS. One way for achieving targeting of specific cell types is suggested that modifying the carrier materials with the targeting moieties, such as ligands, peptides or aptamers. Among them, folate (FA) is one of the most common targeting moieties, and has been covalently attached to a wide array of drug delivery carriers. Another way for drug targeting is using polymer/magnetite particles, which is based on the attractive forces between the applied magnetic field at the target site and the magnetic material dispersed within the drug-loaded polymer particles. Vezzù et al [124] produced lipid microparticles magnetically active by a modified PGSS process.
The EE of magnetite nanoparticles was about 30% and increased with the concentration of magnetite in the initial mixture. The possibility to drive these magnetically active particles by an external magnet was demonstrated in a simple apparatus simulating a vessel of the circulatory system. The coating of magnetite nanoparticles with lipids by the modified-PGSS process presently developed provides materials which may be interesting for diagnostic and therapeutic applications.
Chattopadhyay et al [125] used SAS and SAS-EM processes to produce magnetite-encapsulated PLGA, PMMA and Eudragit RS biodegradable polymer particles via co-precipitation of the polymer with a suspension of magnetite particles in mineral oil and a fatty acid surfactant, where DCM is solvent. Chen et al [126] prepared Fe3O4-PLLA-PEG-PLLA magnetic microspheres (MMPs) in a process of suspension-enhanced dispersion by supercritical CO2, a modified SEDS process by employing the "injector"-like suspension delivery system. Methotrexate-loaded Fe3O4-PLLA-PEG-PLLA MMPs were produced by co-precipitation and microencapsulation processes. The resulting MMPs had a spherical shape, with a good magnetic response, which would have potential as a sustained and targeted drug delivery system when combined with the microencapsulation process.
Tailoring particle microstructures via SCF co-precipitation/encapsulation processes
Besides PS, PSD, morphology and crystal form, particle microstructures like DL and EE are essential to be tailored for SCF co-precipitation/encapsulation processes. Table 4 lists recent SCF co-precipitation/encapsulation processes with an emphasis on the effects of operating parameters on PS, DL and EE. Although a fairly general experimental result of the effects of operating parameters on particle microstructures is not available up to now, some correlations have been proposed and rationally explained on the basis of the thermodynamics and fluid dynamics knowledge.
Typical examples for RESS co-precipitation/encapsulation processes are as follow. Kim et al [134] investigated the effects of fluid phase interactions on particle formation using RESS though combining the solubility data with morphology studies.
The solubility of PLLA and naproxen/ PLLA was measured by using a dynamic flow apparatus, and correlated by the lattice fluid theory of Sanchez and Lacombe. The results suggested that the value of having phase equilibrium data corresponding to morphology studies was the ability to calculate S and accurately describe where precipitation begins to take place in the nozzle. For the co-precipitation of PLLA and naproxen, PLLA microspheres (10-90 m) loaded with naproxen and some free naproxen microparticles (1-5 m) were observed at a pre-expansion T of 114 °C and an extraction P of 190 bar, and the composite particles consisted of a naproxen core surrounded by a thin polymer coating. Songtipya et al [127] produce catechin/PLLA nanoparticles using RESOLV. The results showed that Cd, pre-expansion T and P had no significant effect on the shape and size of composite nanoparticles, which indicated that rapid expansion into a receiving solution effectively interrupted the collision and growth of particles in the free jet. While, the DL and EE of catechin increased with increasing pre-expansion T, and with decreasing pre-expansion P and Cd. The effect of pre-expansion T and P could be explained by the degree of saturation (s) of catechin solutions, increasing pre-expansion T and decreasing pre-expansion P resulted in increasing S and hence a higher nucleation rate of catechin, as well as increased catechin precipitation and entrapment in PLLA along the expansion path. In addition, during rapid expansion, catechin tended to precipitate preferentially in the form of its own particles instead of being entrapped in PLLA with increasing Cd. However, different results were found by Sane et al [128] , where asiatic acid/ PLLA nanoparticles were successfully produced by RESOLV, the results indicated that the DL and EE increased with increasing Cd/Cc, but decreased with increasing pre-expansion T.
Typical examples for PGSS co-precipitation/encapsulation processes are as follow. Rodrigues et al [129] obtained theophylline/HPO microcomposites by PGSS, the results showed that P had no significant effect on PS. However, particles shaped like needles, threads or fibers were more abundant at low pre-expansion P.
Conversely, spheres were predominant at higher pre-expansion P. A reasonable explanation was proposed that at higher pre-expansion P, higher fluid densities are obtained and nucleation starts later in the expansion path. Dissolution studies showed that the Brophy and Deasy model was more adequate to follow the long-time drug dissolution kinetics for the HPO/theophylline system. However, a significant burst effect was observed because considerable amounts of theophylline were located at the particles surface.
de Paz E et al [130] encapsulated -carotene in soybean lecithin using PGSS-drying technique. The influence of process variables on PS was correlated with the atomization process, which was enhanced by increasing the amount of CO2 dissolved in the solution and the volumetric expansion ratio in the nozzle. The results also suggested that a basic requirement for a high EE was a good dispersion of the material to be encapsulated within the carrier matrix in the static mixer. If the pre-expansion T was increased, more water was extracted in the static mixer because the solubility of water in CO2 increased with T, thus, the EE increased when the pre-expansion T was increased. Besides, with a concentrated solution of lecithin already formed in the static mixer, particles or oil droplets can more easily be surrounded by a shell of carrier material that can be mantained upon drying in the spray tower, leading to the prodution of microcapsules and an increase of the EE.
Typical examples for SAS co-precipitation/encapsulation processes are as follow.
Fraile et al [113] encapsulated quercetin in Pluronic F127 poloxamers by SAS process, the results suggested that for low-melting-T polymer, the particles were formed not by nucleation from the solution by the anti-solvent effect, but rather by solidification from a polymer melt. Although operation near the melting region was disadvantageous for the micronization of a pure polymer, it was a favorable condition for co-precipitation experiments, because it can facilitate the encapsulation of the active compound through the formation of a polymer film over active-component particles, avoiding the crystallization of segregated particles of active compound and polymer. The results also indicated that viable conditions for SAS co-precipitation of quercetin with Pluronic F127 were limited to a narrow range of Cd/Cc, in which quercetin particles can act as nucleation sites for the formation of polymer films.
Further, formulations exhibited faster dissolution and a higher final solubility in simulated gastric and intestinal fluids, because of the morphological and structural properties conferred by SAS process.
Montes et al [131] co-precipitated Naproxen with Eudragit or PLLA by SAS process. For Naproxen-Eudragit systems, a larger PS was obtained with a lower P.
This result can be explained by considering that an increase in P at constant T enhances the solvent power of scCO2 toward the solvent, meaning that the liquid solvent molecules are more strongly captured by the CO2, thus reducing the possible interaction between solvent, polymer and drug. The Cd /Cc had a negligible effect on PS but the DL was higher when a higher Cd /Cc ratio was used. The in vitro release profiles of the Naproxen-Eudragit and Naproxen-PLLA systems showed a slower and more controlled release in comparison to the untreated Naproxen.
Chen et al [132] short-term release with burst release followed by sustained release within days or long-term release lasted for weeks.
Zabihi et al [133] successfully encapsulated nano-curcumin in poly(lactic-coglycolic acid) through SAS-EM process, where poly(lactic-co-glycolic acid) solution was sprayed into scCO2 media, in which nano-curcumin particles were fluidized by ultrasonic vibration. The size and yielding of products decreased with increasing Fs.
But the DL first decreases and then increases slightly. Ultrasonic power exhibited a crucial influence on microcapsules characteristics. Products had higher DL and higher yield with increasing ultrasonic power, which was owe to better mixing effects. In the other hand, higher ultrasonic power caused higher fluidization potential by which nano-curcumin was distributed more uniform in precipitation vessel, and resulted more efficient loading. High Fc also improved the DL and PSD when the ultrasonic power was high enough to prevent the particles being pulled out by net flow.
Besides, the effects of the various conditions on PS and PSD in SAS encapsulation process have been discussed in detail by Kalani et al [135] . The main factors for choosing the solvent and biodegradable polymer to produce fine particles to ensure effective drug delivery were emphasized and the effect of polymer structure on drug encapsulation was illustrated.
SUMMARY AND CHALLENGES
Major advances in drug delivery over recent years have highlighted the requirements of efficient methods for producing particles with designated microstructures. SCF processes, as a green and effective alternative to traditional method, have many advantages in particle design and show great potential in drug micronization and co-precipitation/encapsulation.
In this review, a theoretical framework of SCF PD is put forward for particular drug delivery, where the relationships among SCF processes, particle microstructures and performances are discussed in detail. Particle microstructures can be effectively tailored by controlling the operating parameters of SCF processes, where knowledge about the complicated mechanism of particle formation and growth is expected to help the screening and selection of suitable SCF process and its corresponding operating parameters. However, challenges and issues are still existed and need further study for the commercialization of SCF PD, such as following.
(a) Many researches have proved that the macroscopic properties of a drug delivery formulation are depend on the particle microstructures, however, it is still difficult to gain clear and definite requirements of a particular drug delivery on particle microstructures. Tables   Table 1. The most common The polymorph conversion from form I to form II [108] Ibuprofen/ PGSS Operating P: 100-250 bar Operating T: 50-80 o C Fs :1.0 -3.2 ml/min Dispersing matrices: PEG2000 -PEG6000 PS: 20-500 nm PS decreases with P and molecular weight of PEG increases, but increases with T or Fs. Drug release mechanisms from a polymeric material [25] . Fig. 3 . Requirements of particle uptake on surface properties [38] .
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